Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Advanced Parenteral Drug Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Prefilled Syringes, Injectable Vials, Ampoules, Auto-Injectors & Pen Injectors, Infusion Bags & Large Volume Parenteral ), By Molecule Type (Biologics & Biosimilars , Small Molecule Drugs), By Application (Oncology, Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases, Metabolic & Endocrine Disorders, Gastrointestinal Disorders), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers , Home Healthcare Settings, Specialized Care Centers) Companies, and Country Forecast, 2021 to 2034

Global Advanced Parenteral Drug Market size is forecast to increase from $243.04 Billion in 2026 to $748.65 Billion in 2034 at a CAGR of 15.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005437
Pages: 220 Pages

Advanced Ophthalmology Technologies Market Size, Share and Growth Outlook, 2026: Analysis By Technology Type (Diagnostic Technologies, Therapeutic ), By Application (Cataracts, Refractive Errors , Glaucoma, Age-Related Macular Degeneration , Diabetic Retinopathy, Dry Eye Syndrome), By End-User (Hospitals, Specialized Ophthalmic Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Advanced Ophthalmology Technologies Market size is forecast to increase from $8.84 Billion in 2026 to $16.24 Billion in 2034 at a CAGR of 7.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005436
Pages: 216 Pages

Advanced MRI Visualization Systems Market Size, Share and Growth Outlook, 2026: Analysis By Product (Closed MRI Visualization Systems, Open MRI Visualization Systems, Portable ), By Architecture (Enterprise , Standalone Visualization Software Platforms), By Field Strength (Low-to-Mid Field Strength Systems , High Field Strength Systems , Ultra-High Field Strength Systems ), By Application (Neurology and Neuroimaging, Cardiology and Vascular Visualization, Oncology , Orthopedics and Musculoskeletal Imaging, Gastroenterology ), By End-User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers , Academic and Clinical Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Advanced MRI Visualization Systems Market size is forecast to increase from $4.77 Billion in 2026 to $11.15 Billion in 2034 at a CAGR of 11.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005435
Pages: 219 Pages

Advanced Drug Delivery Systems Market Size, Share and Growth Outlook, 2026: Analysis By Delivery Type (Oral Drug Delivery Systems, Injection-Based Drug Delivery Systems, Inhalation , Transdermal Drug Delivery Systems, Transmucosal Drug Delivery Systems, Carrier-Based ), By Technology Platform (Pro-drugs and Stimuli-Responsive Systems, Lipid-Based Nanocarriers, Polymeric Nanocarriers, Smart Implantables and Electro-Responsive Systems, 3D-Printed Formulations and Micro-needles), By Application (Oncology, Cardiovascular Diseases, Metabolic Endocrine Disorders, Central Nervous System , Infectious Diseases, Ophthalmology), By End-User (Hospitals and Specialized Clinics, Home-care and Self-administration Settings, Contract Research & Manufacturing Organizations) Companies, and Country Forecast, 2021 to 2034

Global Advanced Drug Delivery Systems Market size is forecast to increase from $293.64 Billion in 2026 to $454.07 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005434
Pages: 218 Pages

Advanced CT Visualization Systems Market Size, Share and Growth Outlook, 2026: Analysis By Type (3D CT Visualization Systems, 4D CT Visualization Systems, Ultra-High-Resolution CT Visualization Systems), By Solution Type (Enterprise-wide Platforms, Standalone Workstations/Tools), By Deployment Model (On-premise Systems, Cloud-based Solutions, Hybrid Systems), By Clinical Application (Oncology, Cardiovascular, Neurology, Orthopedics & Musculoskeletal, Gastro-Hepatology, Respiratory), By End User (Hospitals, Diagnostic Imaging Centers, Academic & Research Labs, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Advanced CT Visualization Systems Market size is forecast to increase from $5.32 Billion in 2026 to $12.35 Billion in 2034 at a CAGR of 11.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005433
Pages: 219 Pages

Advanced Cancer Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Next-Generation Sequencing , Polymerase Chain Reaction , Immunohistochemistry , In Situ Hybridization , Flow Cytometry, Imaging Technologies , Microarrays), By Test Type (Genetic Biomarker Tests , Protein Biomarker Tests, Circulating Tumor Cells , Circulating Tumor DNA , Exosome Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer , Ovarian Cancer), By End User (Hospitals and Cancer Specialty Centers, Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies) Companies, and Country Forecast, 2021 to 2034

Global Advanced Cancer Diagnostics Market size is forecast to increase from $67.84 Billion in 2026 to $139.2 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005432
Pages: 227 Pages

Advanced Bipolar Direct Energy Devices Market Size, Share and Growth Outlook, 2026: Analysis By Product (Electrosurgical Generator Systems, Bipolar Electrosurgical Devices , Consumables & Accessories ), By Application (General Surgery, Gynecology, Urology, Gastroenterology, Cardiology, Orthopedic Surgery), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Advanced Bipolar Direct Energy Devices Market size is forecast to increase from $4.1 Billion in 2026 to $6.1 Billion in 2034 at a CAGR of 5.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005431
Pages: 226 Pages

Advance Directives Market Size, Share and Growth Outlook, 2026: Analysis By Component (Services , Software & Digital Platforms ), By Demographics (Elderly Population , Middle-Aged Adults , Young Adults ), By Deployment (Standalone Digital Directive Tools, Integrated Electronic Health Record ), By End-User (Business-to-Business / B2B , Business-to-Consumer / B2C) Companies, and Country Forecast, 2021 to 2034

Global Advance Directives Market size is forecast to increase from $176.56 Billion in 2026 to $719.62 Billion in 2034 at a CAGR of 19.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005430
Pages: 220 Pages

Adult Vitamin Gummies Market Size, Share and Growth Outlook, 2026: Analysis By Product (Multivitamin Gummies, Single Vitamin Gummies , Target-Specific Blends ), By Source (Conventional / Synthetic, Organic / Plant-Based / Vegan , Animal-Derived ), By Sugar Content (Regular / Sugar-Sweetened, Low-Sugar / Sugar-Free ), By Distribution Channel (Offline Retail, Online Retail) Companies, and Country Forecast, 2021 to 2034

Global Adult Vitamin Gummies Market size is forecast to increase from $6.79 Billion in 2026 to $10.99 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005429
Pages: 227 Pages

Adult Vaccine Market Size, Share and Growth Outlook, 2026: Analysis By Disease Indication (Influenza, Pneumococcal Disease, Shingles , Human Papillomavirus , Hepatitis , Meningococcal Disease, Diphtheria, Tetanus, and Pertussis , Respiratory Syncytial Virus , Travel Vaccines), By Technology Platform (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant / Subunit / Conjugate Vaccines, mRNA Vaccines, Viral Vector Vaccines, Toxoid Vaccines), By Valence (Monovalent Vaccines, Multivalent Vaccines), By End-User (Private Healthcare Clinics & Physician Offices, Government / Public Hospitals & Health Centers, Retail Pharmacies & Drugstores, Workplace & Institutional Health Centers) Companies, and Country Forecast, 2021 to 2034

Global Adult Vaccine Market size is forecast to increase from $33.79 Billion in 2026 to $59.82 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005428
Pages: 211 Pages